Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 47.00M | $ 128.00M | $ 26.00M | $ 5.00M | $ 0.00 |
Total Assets | $ 11.76B | $ 12.89B | $ 11.26B | $ 10.99B | $ 12.18B |
Total Debt | $ 3.73B | $ 4.55B | $ 3.58B | $ 3.52B | $ 3.97B |
Net Debt | $ 3.68B | $ 4.42B | $ 3.56B | $ 3.51B | $ 3.97B |
Total Liabilities | $ 4.12B | $ 4.90B | $ 3.84B | $ 3.78B | $ 4.27B |
Stockholders Equity | $ 7.57B | $ 7.92B | $ 7.42B | $ 7.21B | $ 7.90B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |